WilfredLieberthalMD

Nephrology • East Setauket, NY

Professor of Medicine

Join to view full profile

Dr. Lieberthal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lieberthal's full profile

Already have an account?

Office
26 Research Way
East Setauket, NY 11733
Phone+1 631-444-0580

Education & Training

Boston University Medical CenterFellowship, Nephrology, 1979 - 1980
Boston University Medical CenterResidency, Internal Medicine, 1976 - 1978
University of the WitwatersrandClass of 1973

Certifications & Licensure

CA State Medical License 2004 - Present
NY State Medical License 2005 - 2022
MA State Medical License 1977 - 2011
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Publications & Presentations

PubMed

20 citations
AMPK-mediated activation of Akt protects renal tubular cells from stress-induced apoptosis in vitro and ameliorates ischemic AKI in vivo.
Wilfred Lieberthal, Meiyi Tang, Mersema Abate, Mark A Lusco, Jerrold S. Levine
American Journal of Physiology. Renal Physiology. 2019-07-01
21 citations
Preconditioning mice with activators of AMPK ameliorates ischemic acute kidney injury in vivo.
Wilfred Lieberthal, Meiyi Tang, Mark A Lusco, Mersema Abate, Jerrold S. Levine
American Journal of Physiology. Renal Physiology. 2016-06-01
16 citations
Apoptotic Cells Activate AMP-activated Protein Kinase (AMPK) and Inhibit Epithelial Cell Growth without Change in Intracellular Energy Stores
Vimal A. Patel, Donald Massenburg, Snezana Vujicic, Lanfei Feng, Meiyi Tang
The Journal of Biological Chemistry. 2015-09-11

Press Mentions

Discovery and Validation of miR-452 as an Effective Biomarker for Acute Kidney Injury in SepsisOctober 25th, 2020
Discovery and Validation of miR-452 as an Effective Biomarker for Acute Kidney Injury in SepsisOctober 25th, 2020

Grant Support

Mechanisms Of Renal Tubular Epithelial Cell InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2001
Hemoglobin Induced Vasoactivity And Renal InjuryNational Heart, Lung, And Blood Institute1994–1997